<?xml version="1.0" encoding="UTF-8"?>
<p>Currently, some new therapeutic options have been evaluated, including antiviral medication such as sofosbuvir. This drug is a direct antiviral inhibitor of the RNA-directed RNA polymerase (NS5B) enzyme of hepatitis C virus, which is essential for viral replication. This molecule incorporates into the RNA of hepatitis C virus and inhibits its replication. This drug is activated in hepatocytes, its prodrug is triphosphorylated and predominantly excreted by the kidney
 <sup>
  <xref rid="B47" ref-type="bibr">47</xref> , 
  <xref rid="B48" ref-type="bibr">48</xref>
 </sup> .
</p>
